Advert - Croma Pharma – Cases AUTH/3644/5/22 and AUTH/3694/10/22

For the poor impression created by the arrangements of a Letybo (botulinum toxin type A) launch symposium held in Monaco which was such that hospitality, including the venue, did not appear to be secondary to the main purpose of the event, which was compounded by signage at the event and noting that hospitality provided, in particular at international meetings, attracted public scrutiny, Croma Pharma was ruled in breach of the following Clauses of the 2021 Code:

Clause 2           - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 5.1        - Failing to maintain high standards

Clause 10.1      - Providing inappropriate hospitality